The persistence of bacille Calmette‐Guerin in the bladder after intravesical treatment for bladder cancer

Wiley - Tập 75 Số 2 - Trang 188-192 - 1995
L. Bowyer1, R. Hall1, James L. Reading1, M.M. Marsh1
1Department of Urology, Freeman Hospital, Newcastle-upon-Tyne, UK

Tóm tắt

Objective To determine the incidence of bacille Calmette‐Guerin (BCG) bacilli persisting in the urinary tract of patients treated previously with intravesical BCG for carcinoma in situ or multiple Ta.T1 transitional cell carcinoma. Patients and methods One‐hundred and twenty‐five patients were treated at the Freeman Hospital, Newcastle upon Tyne, UK over an 8‐year period, 90 of whom submitted early morning urine samples for culture for acid‐fast bacilli at varying intervals following BCG treatment. The records of all patients were reviewed to determine the incidence of caseating granulomata containing acid‐fast bacilli together with the incidence of toxicity and the outcome of treatment. Results Five patients were found to have persisting acid‐fast mycobacteria in their urine or bladder up to 16.5 months after completing intravesical instillations of BCG. In one patient this probably accounted for bladder symptoms that required palliative cystectomy. In four patients the ‘infection’ was not severe. Two patients were treated with antituberculous chemotherapy without complication. Three years after intravesical BCG therapy 36 of 69 patients (52%) had remained tumour free. Conclusion BCG organisms can persist in the urinary tract for at least 16.5 months after the completion of intravesical BCG instillation therapy.

Từ khóa


Tài liệu tham khảo

10.1016/S0022-5347(17)37316-0

Robinson MRG, 1978, Bladder Tumours and Other Topics in Urological Oncology, 171

Steg A, 1989, EORTC Genitourinary Group Monograph 6:BCG in Superficial bladder cancer, 325

10.1016/S0022-5347(17)39731-8

Jakse G, 1992, Societe Internationale d'Vrologie Reports:An Evaluation of Chemotherapy in bladder cancer, 13

10.1016/S0022-5347(17)45922-2

10.1002/path.1711360102

Pagano F, 1989, EORTC Genitourinary Group Monograph 6:BCG in Superficial bladder cancer, 81

Ratliff TL, 1987, Intravesical Bacillus Calmette‐Guerin therapy for murine bladder tumours:Initiation of the response by fibro‐nectin‐mediated attachment of Bacillus Calmette‐Guerin, Can Res, 47, 1762

Morales A, 1992, Immunotherapy for superficial bladder cancer. A developmental and clinical overview, Urol Clin of N Am, 9, 549, 10.1016/S0094-0143(21)00421-3

Ratliff TL., 1989, EORTC Genitourinary Group Monograph 6:BCG in Superficial Bladder Cancer, 107

Martinez‐Pineiro JA., 1978, Bladder Tumours and Other Topics in Vrological Oncology, 175

10.1111/j.1464-410X.1994.tb07548.x

Thông tin
Thông tin xuất bản

Wiley

Tập 75 Số 2

188-192

Thông tin tác giả